JPMorgan analyst Steven Alexopoulos raised the firm’s price target on Synovus to $37 from $35 and keeps an Overweight rating on the shares ahead of the Q2 results. With the peak increase in deposit costs likely in Q2, “another buy signal appears likely” for small cap banks, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SNV: